跳至主要内容
临床试验/EUCTR2020-001329-30-AT
EUCTR2020-001329-30-AT进行中(未招募)1 期

Inhaled Nitric Oxide Gas Therapy in Mechanically Ventilated Patients with Severe Acute Respiratory Syndrome in COVID-19 - NOSARSCOVID19

Massachussetts General Hospital0 个研究点目标入组 200 人开始时间: 2020年4月3日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Adult patients, > 18 year-old
  • 2. Patients admitted to the ICU
  • 3. Patients who are intubated and mechanically ventilated;
  • 4. Confirmed diagnosis of SARS-CoV2 by positive rt-PCR;
  • 5. Severe hypoxemia, defined by PaO2/FiO2 < 300 mmHg.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

排除标准

  • 1. Patients intubated for more than 72 hours from initiation of the treatment gas
  • 2. Physician of record opposed to enrolling the patient due to perceived safety concerns or any condition that does not allow the protocol to be followed safely

研究者

发起方
Massachussetts General Hospital

相似试验

Therapy with Inhaled Nitric Oxide for Patients... | 临床试验